Gulliver W - Search Results

1

ISA247: quality of life results from a phase II, randomized, placebo-controlled study.

Gupta AK, Langley RG, Lynde C, Barber K, Gulliver W, Lauzon G, Aspeslet LJ, Foster RT, Huizinga RB, Yatscoff RW. Gupta AK, et al. Among authors: gulliver w. J Cutan Med Surg. 2008 Nov-Dec;12(6):268-75. doi: 10.2310/7750.2008.07060. J Cutan Med Surg. 2008. PMID: 19317948 Clinical Trial.

2

A partitioned 88-loci psoriasis genetic risk score reveals HLA and non-HLA contributions to clinical phenotypes in a Newfoundland psoriasis cohort.

Bui A, Kumar S, Liu J, Orcales F, Gulliver S, Tsoi LC, Gulliver W, Liao W. Bui A, et al. Among authors: gulliver w. Front Genet. 2023 May 31;14:1141010. doi: 10.3389/fgene.2023.1141010. eCollection 2023. Front Genet. 2023. PMID: 37323656 Free PMC article.

3

Incorporating biologics into the treatment of psoriasis.

Lui H, Langley R, Poulin Y, Gupta AK, Carey W, Guenther L, Searles G, Toole J, Lynde C, Gulliver W, Barber K. Lui H, et al. Among authors: gulliver w. J Cutan Med Surg. 2004 Aug;8 Suppl:8-13. doi: 10.1007/s10227-004-2003-6. J Cutan Med Surg. 2004. PMID: 15655584 Review. No abstract available.

4

The use of alefacept in the treatment of psoriasis.

Langley R, Gupta AK, Poulin Y, Guenther L, Barber K, Gulliver W, Lynde C. Langley R, et al. Among authors: gulliver w. J Cutan Med Surg. 2004 Aug;8 Suppl:14-8. doi: 10.1007/s10227-004-2004-5. J Cutan Med Surg. 2004. PMID: 15655585 Review. No abstract available.

5

A favourable benefit/risk ratio with efalizumab: a review of the clinical evidence.

Poulin Y, Papp KA, Carey W, Gulliver W, Gupta AK. Poulin Y, et al. Among authors: gulliver w. J Cutan Med Surg. 2006;9 Suppl 1:10-7. doi: 10.1007/s10227-006-0102-2. J Cutan Med Surg. 2006. PMID: 16633861 Review.

6

Development and validation of a comprehensive acne severity scale.

Tan JK, Tang J, Fung K, Gupta AK, Thomas DR, Sapra S, Lynde C, Poulin Y, Gulliver W, Sebaldt RJ. Tan JK, et al. Among authors: gulliver w. J Cutan Med Surg. 2007 Nov-Dec;11(6):211-6. doi: 10.2310/7750.2007.00037. J Cutan Med Surg. 2007. PMID: 18042334

7

Prevalence and severity of facial and truncal acne in a referral cohort.

Tan JK, Tang J, Fung K, Gupta AK, Thomas DR, Sapra S, Lynde C, Poulin Y, Gulliver W, Sebaldt RJ. Tan JK, et al. Among authors: gulliver w. J Drugs Dermatol. 2008 Jun;7(6):551-6. J Drugs Dermatol. 2008. PMID: 18561586

8

Divergence of demographic factors associated with clinical severity compared with quality of life impact in acne.

Tan JK, Li Y, Fung K, Gupta AK, Thomas DR, Sapra S, Lynde C, Poulin Y, Gulliver W, Sebaldt RJ. Tan JK, et al. Among authors: gulliver w. J Cutan Med Surg. 2008 Sep-Oct;12(5):235-42. doi: 10.2310/7750.2008.07053. J Cutan Med Surg. 2008. PMID: 18845093

9

Effect of quality of life impact and clinical severity on adherence to topical acne treatment.

Tan JK, Balagurusamy M, Fung K, Gupta AK, Thomas DR, Sapra S, Lynde C, Poulin Y, Gulliver W, Sebaldt RJ. Tan JK, et al. Among authors: gulliver w. J Cutan Med Surg. 2009 Jul-Aug;13(4):204-8. doi: 10.2310/7750.2009.08055. J Cutan Med Surg. 2009. PMID: 19706228

10

Targeting the interleukin-12/23 cytokine family in the treatment of psoriatic disease.

Shear NH, Prinz J, Papp K, Langley RG, Gulliver WP. Shear NH, et al. J Cutan Med Surg. 2008 Dec;12 Suppl 1:S1-10. doi: 10.2310/7750.2008/08070. J Cutan Med Surg. 2008. PMID: 19886505 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters